MCM8 and urinary bladder carcinoma: MCM8 have been found to be aberrantly expressed in a variety of malignancies including gastric cancer [23], cholangiocarcinoma [24], glioblastomas [25], bladder cancer [26], osteosarcoma [27] and myeloid tumors [28].